NL191540C - Compound with anti-hypercholesteremic activity, as well as a pharmaceutical composition containing this compound. - Google Patents
Compound with anti-hypercholesteremic activity, as well as a pharmaceutical composition containing this compound.Info
- Publication number
- NL191540C NL191540C NL8001041A NL8001041A NL191540C NL 191540 C NL191540 C NL 191540C NL 8001041 A NL8001041 A NL 8001041A NL 8001041 A NL8001041 A NL 8001041A NL 191540 C NL191540 C NL 191540C
- Authority
- NL
- Netherlands
- Prior art keywords
- compound
- hypercholesteremic
- activity
- well
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP54017856A JPS5925599B2 (en) | 1979-02-20 | 1979-02-20 | New physiologically active substance monacolin K and its production method |
| JP1785679 | 1979-02-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8001041A NL8001041A (en) | 1980-08-22 |
| NL191540B NL191540B (en) | 1995-05-01 |
| NL191540C true NL191540C (en) | 1995-09-04 |
Family
ID=11955290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8001041A NL191540C (en) | 1979-02-20 | 1980-02-20 | Compound with anti-hypercholesteremic activity, as well as a pharmaceutical composition containing this compound. |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS5925599B2 (en) |
| KR (1) | KR830002801B1 (en) |
| AT (1) | AT373915B (en) |
| AU (1) | AU532626B2 (en) |
| BE (1) | BE881825A (en) |
| CA (1) | CA1129794A (en) |
| CH (1) | CH645890A5 (en) |
| DD (1) | DD154494A5 (en) |
| DE (2) | DE3051175C2 (en) |
| DK (2) | DK149095C (en) |
| ES (1) | ES488796A0 (en) |
| FI (1) | FI66427C (en) |
| FR (1) | FR2449685B1 (en) |
| GB (1) | GB2046737B (en) |
| HU (1) | HU182069B (en) |
| IE (1) | IE49743B1 (en) |
| IT (1) | IT1175260B (en) |
| MX (1) | MX6314E (en) |
| NL (1) | NL191540C (en) |
| NO (1) | NO153974C (en) |
| NZ (1) | NZ192919A (en) |
| PH (1) | PH15145A (en) |
| PL (1) | PL124304B1 (en) |
| SE (1) | SE453301B (en) |
| SG (1) | SG6784G (en) |
| SU (2) | SU1158048A3 (en) |
| ZA (1) | ZA80962B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
| US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| JPS5621594A (en) * | 1979-07-27 | 1981-02-28 | Sankyo Co Ltd | Mb-530b carboxylic acid metal salt and its preparation |
| AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
| PT72394B (en) * | 1980-02-04 | 1982-09-06 | Merck & Co Inc | Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics |
| JPH0692381B2 (en) * | 1980-03-31 | 1994-11-16 | 三共株式会社 | MB-530A derivative |
| JPS56142236A (en) | 1980-04-08 | 1981-11-06 | Sankyo Co Ltd | Ml-236a and mb-530a derivative |
| MX7065E (en) * | 1980-06-06 | 1987-04-10 | Sankyo Co | A MICROBIOLOGICAL PROCEDURE FOR PREPARING DERIVATIVES OF ML-236B |
| JPS5835144A (en) * | 1981-08-27 | 1983-03-01 | Sankyo Co Ltd | Mb-530b derivative and its preparation |
| US4782084A (en) * | 1987-06-29 | 1988-11-01 | Merck & Co., Inc. | HMG-COA reductase inhibitors |
| US4997848A (en) * | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
| CA2062023A1 (en) | 1992-02-10 | 1993-08-11 | Jagroop S. Dahiya | Novel fungal strains and use thereof in antibiotic production |
| JPH07504568A (en) * | 1992-03-04 | 1995-05-25 | 藤沢薬品工業株式会社 | Tetralin derivatives as HMG-CoA reductase inhibitors |
| ZA933359B (en) | 1992-05-15 | 1993-12-08 | Sankyo Co | Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use |
| HU210867B (en) * | 1992-11-04 | 1995-10-30 | Biogal Gyogyszergyar | Method for extraction and purification of mevinolin from culture medium |
| US6812007B1 (en) * | 1992-11-04 | 2004-11-02 | Keri Vilmos | Process for the isolation and purification of mevinolin |
| SI9300303A (en) * | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
| US5409820A (en) * | 1993-08-06 | 1995-04-25 | Apotex, Inc. | Process for the production of lovastatin using Coniothyrium fuckelii |
| US7238348B2 (en) | 1996-09-30 | 2007-07-03 | Beijing Peking University Wbl Corporation Ltd. | Method of treatment of osteoporosis with compositions of red rice fermentation products |
| US6046022A (en) | 1996-09-30 | 2000-04-04 | Peking University | Methods and compositions employing red rice fermentation products |
| UA73074C2 (en) | 1998-03-20 | 2005-06-15 | Method of controlled fermentation for production of lovastatin as hydroxy-acid | |
| CZ20022779A3 (en) | 2000-02-24 | 2003-02-12 | Biogal Gyogyszergyar Rt. | Purification process of fermentation broth |
| WO2001066538A1 (en) | 2000-03-03 | 2001-09-13 | Biogal Gyogyszergyar Rt. | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
| KR20010095780A (en) * | 2000-04-12 | 2001-11-07 | 나가오카 마사시 | Embryo monascus |
| IN192861B (en) | 2000-06-30 | 2004-05-22 | Ranbaxy Lab Ltd | |
| ATE356554T1 (en) * | 2001-02-09 | 2007-04-15 | Unilever Nv | FOODS CONTAINING SOY PROTEIN AND STATIN |
| KR100379075B1 (en) | 2002-03-07 | 2003-04-08 | Jinis Biopharmaceuticals Co | Method for producing low cholesterol animal food product and food product therefrom |
| KR20020093147A (en) * | 2002-05-30 | 2002-12-13 | 지니스생명공학 주식회사 | Preventive and Dietary Supplement for adult chronic disease |
| KR100710500B1 (en) | 2005-05-18 | 2007-04-24 | 고려대학교 산학협력단 | Method for producing Monacolin K using Monascus sp |
| SI2373609T1 (en) | 2008-12-19 | 2013-12-31 | Krka, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
| EP2327682A1 (en) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
| RO128803A0 (en) | 2012-10-12 | 2013-09-30 | Ion Gigel Fulga | Composition for the treatment or prevention of dyslipidemias |
| CN110331151A (en) * | 2019-04-11 | 2019-10-15 | 北京工商大学 | The construction method of purple Monascus mokH gene overexpression bacterial strain |
| CN111297938A (en) * | 2020-03-11 | 2020-06-19 | 北京康立生医药技术开发有限公司 | Method for detecting lovastatin in composition for assisting in reducing blood fat |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5612114B2 (en) * | 1974-06-07 | 1981-03-18 | ||
| JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
| IL60219A (en) * | 1979-06-15 | 1985-05-31 | Merck & Co Inc | Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them |
-
1979
- 1979-02-20 JP JP54017856A patent/JPS5925599B2/en not_active Expired
-
1980
- 1980-02-19 KR KR1019800000654A patent/KR830002801B1/en active
- 1980-02-19 CA CA345,983A patent/CA1129794A/en not_active Expired
- 1980-02-19 IE IE321/80A patent/IE49743B1/en not_active IP Right Cessation
- 1980-02-19 AU AU55673/80A patent/AU532626B2/en not_active Expired
- 1980-02-20 DE DE3051175A patent/DE3051175C2/de not_active Expired
- 1980-02-20 NO NO800451A patent/NO153974C/en unknown
- 1980-02-20 MX MX808652U patent/MX6314E/en unknown
- 1980-02-20 DK DK73080A patent/DK149095C/en not_active IP Right Cessation
- 1980-02-20 SU SU802887300A patent/SU1158048A3/en active
- 1980-02-20 PH PH23668A patent/PH15145A/en unknown
- 1980-02-20 ES ES488796A patent/ES488796A0/en active Granted
- 1980-02-20 FI FI800506A patent/FI66427C/en not_active IP Right Cessation
- 1980-02-20 DD DD80219159A patent/DD154494A5/en unknown
- 1980-02-20 IT IT67262/80A patent/IT1175260B/en active
- 1980-02-20 HU HU80397A patent/HU182069B/en unknown
- 1980-02-20 BE BE0/199476A patent/BE881825A/en not_active IP Right Cessation
- 1980-02-20 NZ NZ192919A patent/NZ192919A/en unknown
- 1980-02-20 FR FR8003662A patent/FR2449685B1/en not_active Expired
- 1980-02-20 PL PL1980222120A patent/PL124304B1/en unknown
- 1980-02-20 SE SE8001339A patent/SE453301B/en not_active IP Right Cessation
- 1980-02-20 AT AT0092980A patent/AT373915B/en not_active IP Right Cessation
- 1980-02-20 GB GB8005748A patent/GB2046737B/en not_active Expired
- 1980-02-20 DE DE3006216A patent/DE3006216C2/en not_active Expired
- 1980-02-20 CH CH136680A patent/CH645890A5/en not_active IP Right Cessation
- 1980-02-20 NL NL8001041A patent/NL191540C/en not_active IP Right Cessation
- 1980-02-20 ZA ZA00800962A patent/ZA80962B/en unknown
- 1980-09-12 SU SU802977031A patent/SU969702A1/en active
-
1984
- 1984-01-24 SG SG67/84A patent/SG6784G/en unknown
-
1989
- 1989-01-18 DK DK021889A patent/DK21889D0/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL191540C (en) | Compound with anti-hypercholesteremic activity, as well as a pharmaceutical composition containing this compound. | |
| NL193457B (en) | Benzoheterocyclic compounds and pharmaceutical composition containing such a compound. | |
| NL940011I2 (en) | Substituted (2-imidazolin-2-yl) aminopirimidines, as well as a pharmaceutical composition with antihypertensive activity, containing one or more of these compounds. | |
| NO810162L (en) | FLUORED VINYLETER COMPOUNDS. | |
| NL7804974A (en) | 2-PENEM-3-CARBONIC ACID COMPOUNDS. | |
| NL190519C (en) | 4-Substituted phenylacetic acid compounds, as well as pharmaceutical preparations. | |
| NL7803721A (en) | GUAJACONIC ACID A AND DIAGNOSTIC AGENT CONTAINING THIS COMPOUND. | |
| IT8019817A0 (en) | IMPROVED CATALYTIC COMPOSITION PREPARATION. | |
| NL189561C (en) | SUBSTITUTED CYCLO-ALKYLIDENE METHYLPHENYLACETIC ACID COMPOUNDS, AND A PHARMACEUTICAL PREPARATION CONTAINING THESE COMPOUNDS. | |
| NL191306C (en) | 4-quinolone derivative, as well as a drug containing this derivative. | |
| NL190781C (en) | N-acylphosphoric triamides, as well as drugs containing N-acylphosphoric triamides. | |
| NL7805588A (en) | 3,3,3-TRIARYLALKYL-4-PHENYLALKYL-4-HYDROXYPIPERIDINS WITH MEDICINAL ACTIVITY. | |
| SE7807024L (en) | INJECTION MATRIX, AS AID FOR DIABETICIANS | |
| NL7811800A (en) | LEAD PYROCHLORINE TYPE COMPOUNDS. | |
| IT7926662A0 (en) | PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DI-HYDRO-3-OXO-2-QUINOXALINES. | |
| DK147300C (en) | 24,24-DIFLUOR-25-HYDROXY-6-ALCOXY-3,5-CYCLOVITAMINE D3 COMPOUNDS | |
| IT8323898A0 (en) | ANTI-ACNE COMPOSITION CONTAINS, AS THE ACTIVE COMPOUND, A DERIVATIVE OF ISOTHIAZOLE-(5,4B) PYRIDINONE-3. | |
| NL191386C (en) | A 16-hydroxy-prostaglandin compound. | |
| ES508222A0 (en) | "PROCEDURE, TO PREPARE DECA-, UNDECA- AND TRIDECAPEPTIDOS WITH TIMICA ACTIVITY". | |
| NL193191B (en) | 1,3-Oxazolidine-2-one derivatives and a pharmaceutical composition containing such a compound. | |
| IT7925538A0 (en) | N-ARIL-N-ACIL-3-AMINO-OXAZOLIDIN2-ONI FUNGICIDES. | |
| NL191709C (en) | C8-substituted ergoline derivatives as well as a drug comprising these derivatives. | |
| IT8025577A0 (en) | LONG-ACTING PHARMACEUTICAL COMPOSITION. | |
| NL930014I2 (en) | 2,4-Dichloro-alpha (N-imidazolylmethyl) -dibenzyl ether derivative and a pharmaceutical composition comprising this compound. | |
| IT1209196B (en) | CLINCHER IMPROVEMENTS. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| A85 | Still pending on 85-01-01 | ||
| BC | A request for examination has been filed | ||
| V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 20000220 |